Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-03-26
1992-04-28
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514432, 514459, 514460, A61K 3135
Patent
active
051090180
ABSTRACT:
Certain novel heterocyclic compounds, their preparation, and their use in inhibiting serine proteases with chymotrypsin-like, elastase-like, and trypsin-like specificity and in the treatment of diseases such as emphysema which involve tissue proteolysis.
REFERENCES:
patent: 4036964 (1977-07-01), Buckle et al.
Chemical Abstracts (Waki et al) 95:161781g (1981).
Davies and Poole, J. Chem. Soc., pp. 1616-1629 (1928).
Milevskaya, Belinskaya, and Yagupol'skii, Zurh. Org. Kmim 9, pp. 2145-2149 (1973).
Tirodkar and Usgaonkar, Ind. J. Chem. 7, pp. 1114-1116 (1969).
Choksey and Usgaonkar, Ind. J. Chem. 14B, pp. 496-598 (1976).
Knott, J. Chem. Soc., pp. 402-410 (1963).
Powers, Ad. in Chem., 198, pp. 347-367 (1982).
Harper Wade
Powers James C.
Georgia Tech Research Corporation
Schenkman Leonard
LandOfFree
Use of heterocyclic inhibitors of serine proteases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of heterocyclic inhibitors of serine proteases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of heterocyclic inhibitors of serine proteases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1249718